Provider profile
Emmes.
Clinical biometrics
Emmes, the CRO business of The Emmes Group, describes biostatistics, analysis plans, adaptive designs, DMC/DSMB reporting, CDISC SDTM/ADaM datasets, data management, EDC build and medical coding for Phase I–IV trials, registries and observational studies, as a full-service CRO or through functional outsourcing. It lists headquarters in Rockville, Maryland, and offices in Canada, India and Europe.
- Website
- theemmesgroup.com (opens in a new tab)
- Sources reviewed
- November 3, 2026 · Source pages re-checked within 4 months
- First published
- November 3, 2026
This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.
Services and capabilities
Services and capabilities
Development experience
Development experience
Development stage
Locations
Locations
- Rockville, United States · Headquarters5Listed as the Emmes Group international headquarters
- Burnaby, Canada · Office5
- Prague, Czech Republic · Office5
- Munich, Germany · Office5
- Bengaluru, India · Office5
- Warsaw, Poland · Office5
- Bucharest, Romania · Office5
- Bratislava, Slovakia · Office5
- Frederick, United States · Office5
Quality and regulatory
Quality and regulatory
The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.
- 21 CFR Part 113
Unknowns and questions to ask
Unknowns and questions to ask
Public sources rarely establish what matters most for a specific project. Confirm directly:
- Named statistician and programming lead for your study, and their recent experience in your indication
- Current capacity and realistic start date for database build and SAP authoring
- Which CDISC standard versions and FDA Data Standards Catalog requirements they will deliver against
- EDC system(s) supported and who holds the licence
- Assumptions behind the budget: number of TLFs, interim analyses, DMC meetings and data transfers
- How change orders are triggered and priced
Not established from reviewed sources: platforms and methods.
Evidence and sources
Evidence and sources
- 1Emmes | TheEmmesGroup (opens in a new tab)Emmes · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 2Biostatistics | TheEmmesGroup (opens in a new tab)Emmes · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 3Clinical Data Management | TheEmmesGroup (opens in a new tab)Emmes · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 4Clinical Services | TheEmmesGroup (opens in a new tab)Emmes · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
- 5Locations | Emmes Group | TheEmmesGroup (opens in a new tab)Emmes · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.
Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.
Contact
Contact
Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.
ArgusBio sourcing
Need help evaluating this provider or comparing alternatives.
Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.
Discuss a sourcing needWe work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.